I. Genka

发表

Complications during clinical courses of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.

S. Oka, N. Tachikawa, Ikumi Genka, 2001, Internal medicine.

Incidence and Risk Factors for Incident Syphilis among HIV-1-Infected Men Who Have Sex with Men in a Large Urban HIV Clinic in Tokyo, 2008−2015

H. Yazaki, S. Oka, S. Shibata, 2016, PloS one.

Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS.

S. Oka, N. Tachikawa, K. Teruya, 2001, AIDS research and human retroviruses.

Accumulation of lopinavir resistance-associated mutations over 3 years follow-up of patients on highly active antiretroviral therapy: implication in salvage therapy.

S. Oka, N. Tachikawa, A. Hachiya, 2001, AIDS.

Cytomegalovirus infection of newborns infected with HIV-1 from mother: case report.

S. Oka, T. Kuratsuji, A. Yasuoka, 2000, Japanese journal of infectious diseases.

HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

H. Yazaki, S. Oka, N. Tachikawa, 2007, AIDS.

Protease inhibitor-associated bone mineral density loss is related to hypothyroidism and related bone turnover acceleration.

S. Oka, K. Tsukada, H. Gatanaga, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Simultaneous vaccination in Japanese travelers.

M. Urashima, S. Kano, K. Kudo, 2007, Travel medicine and infectious disease.

Two cases of long lasting bacteremia due to Mycobacterium avium complex despite new macrolides-containing regimens in patients with acquired immunodeficiency syndrome.

S. Oka, N. Tachikawa, K. Teruya, 2001, Internal medicine.

Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome.

S. Oka, Y. Kikuchi, A. Ishizaki, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis A virus outbreak; a possible indicator of high risk sexual behavior among HIV-1 infected homosexual men.

S. Oka, N. Tachikawa, K. Teruya, 1999, Japanese journal of infectious diseases.

Long-term use of protease inhibitors is associated with bone mineral density loss.

H. Yazaki, S. Oka, Koji Watanabe, 2014, AIDS research and human retroviruses.

Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

H. Yazaki, S. Oka, N. Tachikawa, 2006, AIDS research and human retroviruses.

Anti-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors.

S. Oka, N. Tachikawa, H. Gatanaga, 1999, AIDS research and human retroviruses.

Primary nelfinavir (NFV)-associated resistance mutations during a follow-up period of 108 weeks in protease inhibitor naïve patients treated with NFV-containing regimens in an HIV clinic cohort.

S. Oka, N. Tachikawa, K. Teruya, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Effectiveness of subcutaneous growth hormone in HIV-1 patients with moderate to severe facial lipoatrophy.

S. Oka, N. Tachikawa, H. Gatanaga, 2007, Internal medicine.

Incidence and Risk Factors for Incident Syphilis among HIV-1-Infected Men Who Have Sex with Men in a Large Urban HIV Clinic in Tokyo, 2008−2015

H. Yazaki, S. Oka, S. Shibata, 2016, PloS one.

Various associations of aging and long-term HIV infection with different neurocognitive functions: detailed analysis of a Japanese nationwide multicenter study

H. Yazaki, S. Oka, Yasuaki Yanagawa, 2019, Journal of NeuroVirology.